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INTRODUCTION: Currently, musculoskeletal 
tissue damage is surgically repaired with the aim of 
restoring functionality over form. Any resulting 
tissue damage reduces utility and can increase the 
likelihood of further local injury. Therefore, more 
effective repair and regeneration techniques are 
needed. 
By creating an in vitro musculoskeletal junction 
that closely replicates the form and function of the 
in vivo system, novel materials and chemical 
products could be tested for viability in a more 
representative manner.  
In order to engineer a repeatable system capable of 
scaling-up, a small scale model of bone and muscle 
must be optimised.  
METHODS: 0.75mL 3D type-1 rat-tail collagen 
(2.20mg/mL) neutralised constructs were seeded 
with C2C12 murine myoblast cells at 4x106 
cells/mL as previous described (Sharples et al. 
2012) and set in a gelling area of 11mm x 14mm at 
37oC, 5% CO2 .The constructs were tethered at 
either end by bespoke polythene mesh floatation 
bars to create longitudinal lines of isometric 
tension (Fig 1). Constructs were placed in 20% 
FBS high glucose DMEM for 4 days and then 
cultured in 2% horse serum high glucose DMEM 
to induce differentiation. 
 
RESULTS & DISCUSSION: 
Immunohistochemical staining for the intermediate 
filament protein Desmin showed the capacity for 
alignment and differentiation of C2C12 myoblasts 
within the collagen system at this scale (Fig 1). 
This replicates at a molecular level what is seen in 
larger constructs (Sharples et al. 2012). 
 
CONCLUSIONS: Preliminary indications show 
that a small-scale tissue engineered muscle suitable 
for a preclinical test-bed is viable from a 
phenotypic standpoint. Myotubes are evident and 
aligned however genotypic considerations and co-
cultured limitations with osteoblasts are yet to be 
taken into account. 
 
Fig. 1: Collagen Muscle System: 0.75ml 
collagen/cell hydrogel set between PTFE 
‘floatation bars’. Immunohistochemistry shows 
Desmin intermediate filament (red) and DAPI 
nuclear stain (blue) taken at edge of the gel (40x 
magnification). 
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